Brief: Vanda Pharmaceuticals Reports Positive Results For Tradipitant In Preventing Glp-1 Induced Nausea And Vomiting
17/11/2025 23:41
Nov 17 (Reuters) - Vanda Pharmaceuticals Inc VNDA.O: VANDA PHARMACEUTICALS REPORTS POSITIVE RESULTS FOR TRADIPITANT IN PREVENTING GLP-1 INDUCED NAUSEA AND VOMITING VANDA PHARMACEUTICALS INC - SECONDARY ENDPOINT MET WITH TRADIPITANT REDUCING NAUSEA Source text: ID:nPn6HzbCba Further company coverage: VNDA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vanda Pharmaceuticals
See all newsUS STOCKS ON THE MOVE-Caterpillar, Kimberly-Clark, Bending Spoons
US STOCKS ON THE MOVE-Walmart, Super Micro, FMC
US STOCKS ON THE MOVE-Nvidia, Penske Automotive, ManpowerGroup
US STOCKS ON THE MOVE-Barrick Mining, Venture Global, GE Vernova
Vanda Pharma shares slip as trial failure halts anxiety drug program